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One of today’s most prevalent chronic metabolic diseases is osteoporosis, for it is 
responsible for over 8.9 million fractures annually and approximately one fracture every three 
seconds. Osteoporosis is characterized by compromised bone strength that substantially increases 
one’s risk of fracture. Along with physical activity, there are several nutrients that play a key role 
in regulation of bone metabolism and maintaining optimal bone health, including calcium, 
vitamin D, and iron.  In fact, current research has indicated an association between a deficiency 
in dietary iron status and compromised bone mineral density (BMD), but the details remain 
unclear. The primary objective of this review was to analyze current knowledge on the impact of 
iron deficiency on bone health and propose a new hypothesis on the potential mechanisms 
behind the correlation.  
 Four in vitro animal studies that assessed the affect of reduced dietary intake on various 
bone parameters in weanling rats were reviewed. Correlations between results was analyzed and 
used to determine consistent alterations in bone metabolism due to impaired iron status. The 
findings indicated a significant association between deficient iron and reduced BMD. 
Additionally, the decrease in various biomarkers of both collagen synthesis and osteoblast 
activation implies that these mechanisms may be inhibited when iron is limiting. Therefore, it 
can be hypothesized that iron deficiency significantly impairs bone metabolism due to an 
inhibition of osteoblast activation or collagen synthesis that subsequently reduces bone formation 





The National Institute of Health defines osteoporosis as a skeletal disorder that is 
characterized by compromised bone strength, which subsequently increases an individual’s risk 
of fracture [1]. While it is a chronic metabolic disease that is commonly associated with post-
menopausal women over the age of 50 due to a decrease in estrogen levels, osteoporotic risk 
factors begin in adolescence at the mark of peak bone accretion [1, 2]. Overall, osteoporosis 
causes over 8.9 million fractures annually, equating to approximately one fracture every three 
seconds [3]. The most common sites of osteoporotic fractures are the hip, vertebrae, and distal 
forearm [2]. Numerous factors may contribute to an individual’s risk of developing osteoporosis, 
including minimal weight baring exercise, smoking, and various dietary influences. Although 
calcium and vitamin D are the most widely recognized micronutrients known to be key 
regulators of bone metabolism, additional nutrients have been shown to participate in the 
process, such as vitamin K, copper, phosphorus, and iron [2].  
Iron is a common cofactor in many of the body’s enzymatic processes, with important 
roles in oxygen transport, vitamin D metabolism, and collagen synthesis. It is a micronutrient of 
significant importance to proper physiological functioning, so a deficiency can be very 
detrimental. The most prevalent form of iron deficiency is microcytic anemia, which 
characterized by a low red blood cell count and low hemoglobin levels. Iron deficiency anemia is 
considered the most common and widespread nutritional disorder in the world as well as the only 
nutrient deficiency that is significantly prevalent in industrialized countries [4]. Therefore, it is 
worthwhile to consider the potential repercussions of iron deficiency on metabolic processes 
outside of its primary functions. For instance, due to elevated iron needs during puberty, 
deficiency is particularly common in adolescence, a time period that is also imperative for peak 
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bone accretion [5]. With the increasing prevalence of osteoporosis, there has been heightened 
interest as the potential relationship between iron deficiency and bone health.  
While several lines of evidence have now revealed that an overload of iron can have 
damaging effects on bone, particularly through oxidative damage, the interaction between the 
iron deficiency and bone metabolism remains unclear [5]. Nonetheless, this is an area of vast 
importance due to the widespread prevalence of both iron deficiency and osteoporosis. Previous 
studies have indicated an association between deficient dietary iron intake and reduced bone 
mineral density, but the underlying mechanisms remain unclear. Therefore, the primary objective 
of this review was to analyze current knowledge on the impact of iron deficiency on bone health 
and propose a new hypothesis on the potential mechanisms responsible for the association. 
Specifically, I assessed the findings of four in vitro animal studies on weanling rats, which were 
fed either an iron-deficient or control diet for a period of time and then anesthetized for 




Articles were selected for this review that involved an in vitro animal study on weanling 
rats, which assessed the association between iron deficiency and bone metabolism. Selected were 
the four studies that most specifically fit these criteria. While the broad organization of each of 
the studies was the same, they each differed on various details of their methodology.  
Iron Deficiency Negatively Affects Vertebrae and Femurs of Rats Independently of Energy 
Intake and Body Weight  
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In this study, Medeiros et al placed thirty-two female weanling rats into four groups and 
fed them diets that were 1) control (C), 2) calcium restricted, 3) iron deficient (ID), or 4) pair-fed 
(PF) to the iron-deficient group. After five weeks, the rats were anesthetized and various bone 
parameter measures were assessed. Levels of hematocrit were determined as an indicator of iron-
deficiency. Bone mineral content (BMC) and bone mineral density (BMD) of excised femur 
were measured using dual-energy X-ray absorptiometry (DEXA). Micro-CT was used to 
determine trabecular number, thickness, and separation as well as the structural model index 
(SMI) of the L-3 vertebra trabecular bone. A Pyrilinks-D kit was used to assess twenty-four hour 
urine deoxypryidinoline crosslinks (DPD), which is an indicator of bone resorption. An 
immunoradiometric assay was used to measure serum osteocalcin concentrations, and a 
radioimmunoassay was used for serum 1,25-dihydroxycholcalciferol levels, which is the 
bioactive form of vitamin D [6].  
Severe Iron Deficiency Decreases Both Bone Formation and Bone Resorption in Rats  
In this study conducted by Katsumata et al, eighteen three-week-old, male rats were 
divided into three diet groups, 1) ID, 2) C, or 3) PF to the ID group. After four weeks the rats 
were anesthetized. Serum samples were used to measure hemoglobin and hematocrit 
concentrations as indicators of iron deficiency. These samples were also used to assess serum 
total protein, albumin, and globulin concentrations, as well as serum parathyroid hormone 
(PTH), insulin-like growth factor-1 (IGF-1), osteocalcin, and 1,25-dihydroxycholcalciferol 
concentrations. Twenty-four hour urine samples were used to measure urinary C-terminal 
telopeptide of type 1 collagen (CTx) and DPD excretion. The BMC and BMD of the femur were 
obtained using DEXA, and the trabecular number, separation, and thickness of the L-2 vertebra 
were measured along with other bone histomorphometric measures, including the osteoid volume 
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(OV/TV), mineralizing surface (MS/TS), mineral apposition rate (MAR), and bone formation 
rate (BAR) [7].  
Severe Nutritional Iron-Deficiency Anemia has a Negative Effect on Some Bone Turnover 
Markers in Rats 
This study by Diaz-Castro et al divided thirty male weanling rats into either a C group or 
an ID group. After forty days, the rats were anesthetized, and serum was collected and used to 
determine hematocrit and hemoglobin concentrations. These samples were also used to assay 
serum 25-dihydroxycholcalciferol, aminoterminal propeptides of type 1 collagen (PINP), 
tartrate-resistant acid phosphatase (TRACP 5b), CTx degradation products, and PTH. PINP is an 
important marker of bone formation, while TRACP 5b indicates bone resorption. The 
concentration of calcium and phosphorus in the femur was measured with atomic absorption 
spectrophotometry and used to indicate bone mineralization [8].  
Iron Deficiency Negatively Affects Bone Quality And Microarchitecture In Weanling Male 
Sprague Dawley Rats 
In this study by Shawron, thirty weanling rats were divided into one of three groups, 1) 
ID, 2) C, or 3) PF to the ID diet. After thirty-five days the rats were anesthetized, and serum 
samples were collected and used for assessment of hemoglobin and hematocrit. BMD and BMC 
in the tibia were measured with DEXA, and the micro-CT was used to determine trabecular 






All of the results presented are represented in Table 1 below.  
Indicators of Iron Deficiency  
Each of the studies had sufficient biomarkers that revealed the presence of iron 
deficiency in the ID animals as compared to the C or PF groups. The ID animals in the studies of 
Katsumata et al, Diaz-Castro et al, and Shawron each had decreased hemoglobin levels, and the 
ID animals in all four studies had decreased hematocrit concentrations [6, 7, 8].  
Serum Vitamin D, Calcium, and Protein  
Both Medeiros et al and Katsumata et al showed no difference in the concentration of 
serum 1,25-dihydroxycholcalciferol in the ID compared to C and PF groups [6, 7]. Similarly, 25-
hydroxycholcalciferol in the Diaz-Castro et al study was not significantly different in the ID 
group compared to the C group [8]. In the Katsumata et al study apparent calcium absorption and 
rate of absorption were decreased in the in the ID group compared to the PF and C animals. 
There was also a significant decrease in the concentration of total serum protein, serum albumin, 
and serum globulin in the ID group in this study [7].  
Indicators of Bone Turnover  
In the Medeiros et al study there was no significant difference in serum osteocalcin 
concentration or urinary DPD crosslinks in the ID group versus the C or PF groups [6]. In the 
Katsumata et al study levels of serum IGF-1, serum osteocalcin, and urinary DPD excretion 
significantly decreased in the ID group compared to the PF and C groups, while levels of urinary 
CT increased. They determined no difference in the levels of PTH between the groups [7]. In the 
study by Diaz-Castro et al, levels of PINP decreased, while levels of CTx, TRACP 5b, and PTH 
increased [8].  
BMC and BMD  
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 Both the study by Medeiros et al and the study by Katsumata et al revealed a significant 
decrease BMD and BMC in the ID femur [6, 7]. Similarly, the study by Shawron revealed a 
significant decrease in the BMD and BMC of both the tibia and lumbar vertebra [2]. Diaz-Castro 
et al’s study revealed significantly less calcium and phosphorus in the femur of the ID rats 
compared to the control rats [8].  
Bone Histomorphometric Parameters of the Lumbar Vertebra  
Medeiros et al and Shawron both revealed a significant decrease in trabecular number as 
well as a significant increase in trabecular separation in the lumbar vertebra of the ID animals 
compared to the PF and C animals [6, 2]. They also revealed a slight decrease in trabecular 
thickness and an increase in the SMI, indicative of an increased fracture risk [6, 2]. In the 
Katsumata et al study, there was a significant decrease in OV/TV, MS/TS, MAR, and BFR in the 
ID versus the PF and C group [7].  
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TABLE 1 Indicators of Iron Deficiency of Bone Metabolism 
 
  Medeiros  Katsumata  Diaz-Castro Shawron 
Iron Deficiency          
Hemoglobin   Decrease Decrease Decrease 
Hematocrit Decrease Decrease Decrease  Decrease 
Serum Concentrations         
1,25-dihydroxycholcalciferol No Change No Change     
25-hydroxycholecalciferol     No Change   
Total Protein   Decrease     





Indicators of Bone Turnover         
Serum Osteocalcin No Change Decrease 
  










TRACP 5b     Increase   
PTH 
 
No Change Increase 
 
BMC/BMD         
BMD Decrease Decrease 
 
Decrease 
BMC Decrease Decrease   Decrease 




Bone Histomorphometry          
Trabecular Number Decrease No Change 
 
Decrease 
Trabecular Separation Increase No Change   Increase 
Trabecular Thickness  Decrease No Change 
 
Decrease 










BFR   Decrease     
 
 
Table 1 Shows the different bone parameters measured in each study. The primary author of each article is indicated 
in the columns, and the rows represent each biomarker. Increase means that levels significantly rose with the ID diet 
compared to the control diet, decrease means they were significantly reduced, and no change indicates that there was 




The results from each of these studies reveal a significant decrease in bone mineral 
density (BMD) and bone mineral content (BMC) in the iron-deficient (ID) animals as compared 
to the pair fed (PF) or control (C) animals, which is supportive of the proposed idea that iron 
deficiency may play a dominant cause in bone loss through impaired bone metabolism [6, 7, 8, 
2]. However, BMD and BMC were assessed at different anatomical locations in each of the 
studies, Medeiros et al and Katsumata et al in the femur and Shawron in the tibia and vertebra, 
which may have limited the consistency of the results, due to the anatomical differences [6, 7, 2].  
Trabecular morphology is another important indicator of bone composition as it provides 
a more specific look into bone microarchitecture [2]. The articles showed some discrepancy 
between studies on the influence of iron on the trabecular bone of the lumbar vertebra. Medeiros 
et al and Shawron both indicated a significant increase in the separation and structural model 
index (SMI), and a reduction in the number and thickness of trabecular lumbar vertebral bone of 
the iron deficient animals, but Katsumata et al found no significant differences in any of these 
parameters [6, 7, 2]. However, the discrepancy in the data may be due to differences in levels of 
induced iron deficiency in the studies.  
While evidence from the studies of Katsumata et al and Diaz-Castro et al suggest 
potential alterations of osteoclast activity iron reduction in animals, there was not consistent 
evidence of this shown throughout the studies to draw a conclusion [7, 8]. There is, however, 
much more persistent evidence between all four of the studies that suggests that alterations in 
osteoblast activity may have caused reduced bone formation in the iron deficient animals. To 
investigate this association, several important biomarkers of bone formation were measured in 
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each of the studies including insulin-like growth factor-1 (IGF-1), osteocalcin, and osteoid. IGF-
1 is a prominent hormonal regulator of bone formation, which stimulates bone collagen and 
matrix synthesis as well as the replication of osteoblasts [9]. Osteocalcin is a major 
noncollagenous protein of the bone matrix that is secreted by osteoblasts and important for 
maximal bone matrix strength [7]. Osteoid proteins are secreted by osteoblasts and make up the 
unmineralized, organic portion of the matrix that is composed of both collagen and 
noncollagenous proteins, including osteocalcin [9].  
Katsumata et al found a significant decrease in serum IGF-1 and osteocalcin 
concentrations with iron impairment, as well as a significant reduction in osteoid volume in these 
animals [7]. The significant decrease in these markers, as well as the negative alterations in 
mineralizing surface (MS/TS), mineralization apposition rate (MAR), and bone formation rate 
(BFR) parameters in the ID group, suggests that dietary iron deficiency may have significantly 
impaired bone formation leading to a decrease in BMD/BMC [7]. Medeiros et al did not find a 
significant decrease in serum osteocalcin concentrations in the ID group versus the PF or C 
groups. This may have had to do to will the degree of iron deficiency in the animals, for the 
severity of iron impairment was greater in the study by Katsumata et al [6, 7].  
Another important biomarker for bone formation assessed by Diaz-Castro et al was the 
level of propeptides of type 1 procollagen (PINP). The decrease in the level of PINP in the 
anemic group compared to the control group suggests that the amount of bone matrix developed 
in these animals may have also been limited, which subsequently inhibited their bone 
mineralization [8]. The increased degradation of C-terminal telopeptides of type 1 collagen 
(CTx) in these animals also supported this idea as it demonstrated a reduction of cross-linking 
 13 
the collagen fibers, which may have led to overall weaker collagen fibers, greater bone fragility, 
and an increased fracture risk [8].  
There are a number of molecular mechanisms through which iron deficiency has been 
suggested to affect bone metabolism. One of the proposed mechanisms considers the role of iron 
in the second hydroxylation of vitamin D to produce 1,25-dihydroxycholcalciferol, the vitamin’s 
bioactive form that plays an important role in calcium absorption [10]. The enzyme responsible 
for this hydroxylation, 25-hydroxycholcalciferol 1(alpha)-hydroxylase, is a three-component 
system composed of a flavoprotein, an iron-sulfur protein, and a cytochrome P-450 [8]. A lack in 
iron could potentially inhibit this enzyme leading to impairment in calcium absorption [8]. While 
the study by Katsumata et al speculated that a reduction in 1,25-dihydroxycholcalciferol caused 
by a depletion of iron might have led to the decreased BMD and BMC in the ID rats, the results 
from both this study as well as the study by Medeiros et al. do not necessarily support this 
speculation, as neither study showed a significant difference in serum 1,25-
dihydroxycholcalciferol concentrations [6, 7].  However, 1,25-dihyroxycholcalciferol has a 
relatively short half-life, making it a poor indicator of serum vitamin D levels, which could 
explain the lack of evidence behind this mechanism in the studies.  
A second proposed mechanism examines the role of iron as a cofactor in collagen 
synthesis and maturation. Approximately ninety percent of total bone protein is made of type I 
collagen, which is the major organic component of bone matrix [8, 10]. Iron serves as a 
necessary cofactor for prolyl and lysyl hydroxylases that are responsible for catalyzing the 
crosslinking of type 1 collagen. A situation of limiting iron could inhibit this process, 
subsequently leading to weaker collagen fibers, greater bone fragility, and an increased fracture 
risk [10]. Many of the results from the studies in review support this potential mechanism, as 
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indicated by the decreased levels of PINP and elevated levels of CTx found by Diaz-Castro et al 
[8]. Katsumata et al found elevated levels of PINP as well, indicative of a reduction in cross-
linking [7]. Weaker collagen fibers would consequently impair bone mineralization leading to 
the decreased bone mineralization represented in all of the studies [6, 7, 8, 2]. However, other 
biomarkers, such as decreased levels of osteocalcin and IGF-1 suggest that an iron deficiency 
may inhibit osteoblast function and bone formation through an alternate mechanism. Therefore, 
the relationship between iron, osteoblast activity, and bone formation should be examined in 
future studies.  
One mechanism that has yet to be explored is the potential impact of iron on protein 
metabolism. The results of the study by Katsumata et al reveal decreased serum protein, 
albumin, and globulin concentrations in the iron deficient animals versus the pair fed and control 
animals [7]. These findings suggest that dietary iron deficiency may impair protein synthesis 
and/or utilization, which could in turn interfere with proper bone metabolism [7]. However, 





 In conclusion, the evidence presented in each of the studies reviewed is supportive of the 
proposed association between dietary iron deficiency and altered bone metabolism in mice. 
While many mechanisms for this correlation have been proposed, the details remain unclear. 
Several biomarkers of bone formation and resorption were measured in each of the four articles 
to gain better insight into the impact of iron on bone physiology. While the evidence for bone 
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resorption seemed somewhat inconsistent, there appeared to be more substantiated evidence in 
support of a potential association between iron and bone formation, either through collagen 
synthesis or osteoblast activity. Therefore, it can be hypothesized that iron deficiency 
significantly impairs bone metabolism due to an inhibition of osteoblast activation or collagen 
synthesis that subsequently reduces bone formation and mineralization. However, further 
research will need to be conducted to more specifically assess the effect of iron deficiency on 
collagen synthesis and osteoblast activation. Future studies are also needed to look into the 
association between iron and vitamin D and the potential role it could play on bone metabolism, 
as previous research has been inconclusive. Additionally, further investigations need to be 
conducted to assess these findings on humans and more specifically look into the role of iron 
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